<?xml version="1.0" encoding="UTF-8"?>
<abstract>
 <title>Abstract</title>
 <p>Seroprevalence studies provide a more accurate picture of coronavirus disease 2019 (COVID‐19) than PCR‐confirmed cases as antibodies can be detected in mild or asymptomatic cases who otherwise remain undiagnosed. Seroprevalence can also be used as an indicator of population immunity.</p>
 <p>This article is protected by copyright. All rights reserved.</p>
</abstract>
